S&P 500   3,362.03 (-0.54%)
DOW   29,185.16 (-0.72%)
QQQ   234.00 (-0.27%)
AAPL   317.44 (-2.31%)
FB   217.31 (+1.46%)
MSFT   186.78 (+0.77%)
GOOGL   1,520.84 (+0.14%)
AMZN   2,139.41 (+0.21%)
CGC   22.21 (+0.36%)
NVDA   291.91 (+0.73%)
BABA   218.41 (-0.56%)
MU   57.72 (-1.33%)
GE   12.82 (-0.16%)
TSLA   843.01 (+5.37%)
AMD   56.44 (+2.04%)
T   38.16 (-0.24%)
ACB   1.59 (+0.63%)
NFLX   387.40 (+1.84%)
PRI   135.27 (-1.15%)
BAC   34.24 (-1.75%)
DIS   138.39 (-0.82%)
GILD   67.18 (-0.56%)
S&P 500   3,362.03 (-0.54%)
DOW   29,185.16 (-0.72%)
QQQ   234.00 (-0.27%)
AAPL   317.44 (-2.31%)
FB   217.31 (+1.46%)
MSFT   186.78 (+0.77%)
GOOGL   1,520.84 (+0.14%)
AMZN   2,139.41 (+0.21%)
CGC   22.21 (+0.36%)
NVDA   291.91 (+0.73%)
BABA   218.41 (-0.56%)
MU   57.72 (-1.33%)
GE   12.82 (-0.16%)
TSLA   843.01 (+5.37%)
AMD   56.44 (+2.04%)
T   38.16 (-0.24%)
ACB   1.59 (+0.63%)
NFLX   387.40 (+1.84%)
PRI   135.27 (-1.15%)
BAC   34.24 (-1.75%)
DIS   138.39 (-0.82%)
GILD   67.18 (-0.56%)
S&P 500   3,362.03 (-0.54%)
DOW   29,185.16 (-0.72%)
QQQ   234.00 (-0.27%)
AAPL   317.44 (-2.31%)
FB   217.31 (+1.46%)
MSFT   186.78 (+0.77%)
GOOGL   1,520.84 (+0.14%)
AMZN   2,139.41 (+0.21%)
CGC   22.21 (+0.36%)
NVDA   291.91 (+0.73%)
BABA   218.41 (-0.56%)
MU   57.72 (-1.33%)
GE   12.82 (-0.16%)
TSLA   843.01 (+5.37%)
AMD   56.44 (+2.04%)
T   38.16 (-0.24%)
ACB   1.59 (+0.63%)
NFLX   387.40 (+1.84%)
PRI   135.27 (-1.15%)
BAC   34.24 (-1.75%)
DIS   138.39 (-0.82%)
GILD   67.18 (-0.56%)
S&P 500   3,362.03 (-0.54%)
DOW   29,185.16 (-0.72%)
QQQ   234.00 (-0.27%)
AAPL   317.44 (-2.31%)
FB   217.31 (+1.46%)
MSFT   186.78 (+0.77%)
GOOGL   1,520.84 (+0.14%)
AMZN   2,139.41 (+0.21%)
CGC   22.21 (+0.36%)
NVDA   291.91 (+0.73%)
BABA   218.41 (-0.56%)
MU   57.72 (-1.33%)
GE   12.82 (-0.16%)
TSLA   843.01 (+5.37%)
AMD   56.44 (+2.04%)
T   38.16 (-0.24%)
ACB   1.59 (+0.63%)
NFLX   387.40 (+1.84%)
PRI   135.27 (-1.15%)
BAC   34.24 (-1.75%)
DIS   138.39 (-0.82%)
GILD   67.18 (-0.56%)
Log in

NASDAQ:PMTI - Palomar Medical Technologies Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume128,366 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Palomar Medical Technologies, Inc (Palomar) is a researcher and developer of aesthetic light-based systems for hair removal and other cosmetic procedures, including both lasers and high powered lamps. The Company offers a range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, and other skin treatments. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
Current SymbolNASDAQ:PMTI
CUSIP69752930
Phone+1-781-9932300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for PMTI and its competitors with MarketBeat's FREE daily newsletter.


Palomar Medical Technologies (NASDAQ:PMTI) Frequently Asked Questions

What is Palomar Medical Technologies' stock symbol?

Palomar Medical Technologies trades on the NASDAQ under the ticker symbol "PMTI."

Has Palomar Medical Technologies been receiving favorable news coverage?

Media headlines about PMTI stock have trended extremely negative on Tuesday, according to InfoTrie. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Palomar Medical Technologies earned a daily sentiment score of -5.0 on InfoTrie's scale. They also assigned news stories about the healthcare company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Palomar Medical Technologies.

Who are some of Palomar Medical Technologies' key competitors?

What other stocks do shareholders of Palomar Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Palomar Medical Technologies investors own include Genocea Biosciences (GNCA), FedNat (FNHC), Dyax (DYAX), Derma Sciences (DSCI), Concert Pharmaceuticals (CNCE), Cara Therapeutics (CARA), BioCryst Pharmaceuticals (BCRX), Ariad Pharmaceuticals (ARIA), Arcturus Therapeutics (ARCT) and AGNC Investment (AGNC).

Who are Palomar Medical Technologies' key executives?

Palomar Medical Technologies' management team includes the folowing people:
  • Joseph P. Caruso, Chairman of the Board, President, Chief Executive Officer (Age 54)
  • Paul S. Weiner, Chief Financial Officer, Treasurer (Age 53)
  • Louis P. Valente, Director (Age 81)
  • Jeanne Cohane, Independent Director (Age 65)
  • Damian N. Dell'Anno, Independent Director
  • Nicholas P. Economou Ph.D., Independent Director (Age 63)
  • James G. Martin Ph.D., Independent Director (Age 78)

What is Palomar Medical Technologies' official website?

The official website for Palomar Medical Technologies is http://www.palomarmedical.com/.

How can I contact Palomar Medical Technologies?

Palomar Medical Technologies' mailing address is 15 Network Drive, BURLINGTON, MA 1803, United States. The healthcare company can be reached via phone at +1-781-9932300.


MarketBeat Community Rating for Palomar Medical Technologies (NASDAQ PMTI)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  82 (Vote Outperform)
Underperform Votes:  113 (Vote Underperform)
Total Votes:  195
MarketBeat's community ratings are surveys of what our community members think about Palomar Medical Technologies and other stocks. Vote "Outperform" if you believe PMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: Quantitative Easing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel